| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.987 | 9.893 | 12.865 | 22.735 | 19.966 | 16.039 | 15.038 | 13.455 | 20.755 | 8.948 |
| Total Income - EUR | 3.987 | 9.893 | 12.865 | 22.735 | 19.966 | 16.039 | 15.039 | 13.641 | 20.844 | 8.957 |
| Total Expenses - EUR | 4.904 | 5.816 | 7.909 | 14.443 | 20.167 | 8.811 | 9.496 | 11.727 | 13.734 | 11.693 |
| Gross Profit/Loss - EUR | -918 | 4.078 | 4.956 | 8.292 | -201 | 7.228 | 5.544 | 1.914 | 7.111 | -2.736 |
| Net Profit/Loss - EUR | -1.037 | 3.781 | 4.570 | 8.064 | -401 | 6.747 | 5.147 | 1.570 | 6.158 | -2.736 |
| Employees | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Kamaro Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.107 | 1.591 | 4.640 | 3.305 | 2.597 | 1.949 | 16.371 | 12.738 | 8.119 | 3.652 |
| Current Assets | 619 | 1.784 | 3.714 | 5.468 | 3.927 | 9.747 | 12.512 | 14.692 | 23.777 | 24.028 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 221 | 1.251 | 725 | 1.084 | 1.709 | 1.644 | 4.904 | 4.227 | 7.075 | 7.093 |
| Cash | 398 | 534 | 2.988 | 4.384 | 2.218 | 8.102 | 7.608 | 10.465 | 16.703 | 16.935 |
| Shareholders Funds | -992 | 2.799 | 7.322 | 8.116 | 3.121 | 9.809 | 14.738 | 16.354 | 22.463 | 19.602 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.718 | 577 | 1.094 | 856 | 3.498 | 1.915 | 14.401 | 11.834 | 10.354 | 9.075 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Kamaro Med Srl